Publications by authors named "Thomas Moehler"

Claim this Profile
U
Uptake of novel therapies into first-line treatment for acute myeloid leukemia patients: EU4 + UK perspective.
Magdalena Ruiz, Kriti Jindal, Vicky Casey, Luana Margotto Soares, Fil Manuguid, Thomas Moehler

Future Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma.
Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M Poos, Britta Besemer, Thomas Moehler

Blood· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line therapy with bendamustine/prednisone/bortezomib-A GMMG trial for non-transplant eligible symptomatic multiple myeloma patients.
Wolfgang Knauf, Gerrit Dingeldein, Rudolf Schlag, Manfred Welslau, Thomas Moehler

Eur J Haematol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and therapeutic approaches to multiple myeloma patients: 'Real-world' data from representative multicentre treatment surveys in Germany between 2008 and 2011.
Thomas M Moehler, Maximilian Merz, Lenka Kellermann, Hartmut Goldschmidt, Wolfgang Knauf

Oncol Lett· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma.
Jens Hillengass, Judith Ritsch, Maximilian Merz, Barbara Wagner, Christina Kunz, Thomas M Moehler

Br J Haematol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study.
Maximilian Merz, Thomas M Moehler, Judith Ritsch, Tobias Bäuerle, Christian M Zechmann

Eur Radiol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Furan-Based Lewis-Y-(CD174)-Saccharide Mimetic Inhibits Endothelial Functions and In Vitro Angiogenesis.
Sandra Sauer, Tobias Meissner, Thomas Moehler

Adv Clin Exp Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic contrast-enhanced magnetic resonance imaging for assessment of antiangiogenic treatment effects in multiple myeloma.
Maximilian Merz, Judith Ritsch, Christina Kunz, Barbara Wagner, Sandra Sauer, Thomas Moehler

Clin Cancer Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The glycome of normal and malignant plasma cells.
Thomas M Moehler, Anja Seckinger, Dirk Hose, Mindaugas Andrulis, Jèrôme Moreaux

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib in patients with refractory or recurrent multiple myeloma.
Anna Yordanova, Dirk Hose, Kai Neben, Mathias Witzens-Harig, Ines Gütgemann, Thomas Moehler

Hematol Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma.
Britta Auel, Hartmut Goldschmidt, Thomas Geer, Thomas M Moehler, Uwe Platzbecker

Indian J Hematol Blood Transfus· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial.
Martin Kropff, Honorata Giongco Baylon, Jens Hillengass, Tadeusz Robak, Roman Hajek, Thomas M Moehler

Haematologica· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.
Bernard Klein, Anja Seckinger, Thomas Moehler, Dirk Hose

Recent Results Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management.
Jens Hillengass, Thomas Moehler, Michael Hundemer

Recent Results Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy of relapsed and refractory multiple myeloma.
Thomas Moehler, Hartmut Goldschmidt

Recent Results Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined phase I/II study of imexon (AOP99.0001) for treatment of relapsed or refractory multiple myeloma.
Thomas M Moehler, Reinhard Feneberg, Anthony Dick Ho, Anatoly K Golenkov, Heinz Ludwig

Anticancer Drugs· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional regulation of the vascular endothelial glycome by angiogenic and inflammatory signalling.
Martina Willhauck-Fleckenstein, Thomas M Moehler, Anette Merling, Susann Pusunc, Hartmut Goldschmidt

Angiogenesis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.
Jens Hillengass, Kerstin Fechtner, Marc-André Weber, Tobias Bäuerle, Sofia Ayyaz, Thomas M Moehler

J Clin Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging.
Tobias Bäuerle, Jens Hillengass, Kerstin Fechtner, Christian M Zechmann, Lars Grenacher, Thomas M Moehler

Radiology· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation.
Jens Hillengass, Christian Zechmann, Tobias Bäuerle, Barbara Wagner-Gund, Christiane Heiss, Thomas Moehler

Clin Cancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone.
Ulrike Klein, Florentina Kosely, Jens Hillengass, Michael Hundemer, Stefan Schmitt, Thomas Moehler

Ann Hematol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma.
Jens Hillengass, Christian M Zechmann, Andreas Nadler, Dirk Hose, Friedrich W Cremer, Thomas M Moehler

Int J Cancer· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of alpha 1-2-fucosyltransferase I (FUT1) and surface-expressed Lewis(y) (CD174) in first endothelial cell-cell contacts during angiogenesis.
Thomas M Moehler, Sandra Sauer, Maximilian Witzel, Mindaugas Andrulis, Juan J Garcia-Vallejo

J Cell Physiol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
Mathias Witzens-Harig, Rüdiger Waldherr, Joerg Beimler, Martin Zeier, Jochen Hansmann, Thomas Moehler

Ann Hematol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Where is the primary tumour?
Christian M Zechmann, Frederik L Giesel, Jens Hillengass, Amit Mehndiratta, Kai Neben, Thomas Moehler

Lancet· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis